What is Global Health Ltd (MEDANTA) share price today?

Global Health Ltd (MEDANTA) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/MEDANTA for the latest live price, technical analysis, and AI-powered insights.

How to analyse MEDANTA stock?

VestAI provides comprehensive MEDANTA stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Global Health Ltd in?

Global Health Ltd (MEDANTA) is in the Healthcare sector, Hospital industry on the NSE.

Global Health Ltd

Name: Global Health Ltd (MEDANTA) Financial Metrics
Creator: VestAI

MEDANTA

NSE· Healthcare

₹1,314.00

-18.20 (-1.37%)

Updated 08:45 am IST

52W Low · ₹959.6552W High · ₹1,456.50

Near 52W High

Market Cap

₹33320.64L Cr

Volume

44.4K

Prev Close

₹1,338.50

ISIN

INE474Q01031

Orion Score

Fundamentals-based quality & risk · not a recommendation

67/100

Quality

Global Health Ltd scores 67/100 (Quality) on the Orion Score — strong business quality (76), strong growth (79), moderate balance-sheet safety (69) and rich valuation (18). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Short track record (4 yrs of data)

Forensic accounting

Piotroski F 4/9Altman Z Safe(5.92)Beneish M Clean(-2.32)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

50/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.30x — lean balance sheet

QUALITY

Average

ROCE 13.2% — decent returns

MOMENTUM

Neutral

RSI 62.6 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 59.87
ROCE: 13.20%
ROE (1Y): 15.03%
D/E Ratio: 0.30x
OPM: 15.29%
TTM EPS: ₹20.71
Dividend Yield: 4.00%
Qtrly Sales: ₹1,159.05 Cr
Qtrly Profit: ₹143.99 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹1,159.05	₹143.99	15.3%	₹5.35
Q3 2026	₹1,121.05	₹95.02	13.9%	₹3.54
Q2 2026	₹1,099.22	₹158.44	16.5%	₹5.89
Q1 2026	₹1,030.84	₹159.01	17.6%	₹5.91
Q4 2025	₹931.25	₹101.4	18.8%	₹3.77

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹4,410.27	₹556.46	₹1,016.67	15.8%
FY 2025	₹3,692.34	₹481.44	₹906.26	18.5%
FY 2024	₹3,240.94	₹478.19	₹872.37	20.3%
FY 2023	₹2,682.8	₹326.08	₹676.67	18.6%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
MEDANTA ★	₹33,321 Cr	59.87	13.20%	15.03%	0.30x	15.29%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹4,766.23	₹4,304.07	₹4,115.97	₹3,145.52
Equity	₹3,386.41	₹2,905.63	₹2,428.21	₹1,616.01
Total Debt	₹717.73	₹801.87	₹1,121.95	₹1,108.92
Cash	₹230.2	₹424.61	₹767.24	₹119.43
Net Debt	₹97.68	—	₹74.98	₹718.43
Working Capital	₹914.31	₹891	₹1,006.93	₹392.25

Shareholding Pattern

Q1 FY2027

Promoter

67.5%

FII

11.92%

DII

9.75%

Public

10.83%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	67.5% ↑	11.92% ↑	9.75% ↓	10.83% ↓
Q3 FY2026	33.01%	10.54% ↓	13.99% ↑	42.41% ↓
Q2 FY2026	33.01%	11.41% ↓	12.97% ↑	42.56% ↓
Q1 FY2026	33.01% ↓	11.54% ↓	12.2% ↑	43.19% ↓
Q4 FY2025	33.03%	11.76% ↓	11.93% ↑	43.28% ↓
Q3 FY2025	33.03%	12.48% ↑	10.51% ↓	43.98% ↑
Q2 FY2025	33.04%	12.21% ↓	11.11% ↑	43.64% ↑
Q1 FY2025	33.04%	12.94%	10.57%	43.44%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

102 mutual fund schemes

Invesco India Mid Cap Fund Direct GrowthINVESCO

4.39%

₹605 Cr

Invesco India Focused Fund Direct GrowthINVESCO

3.68%

₹207 Cr

Motilal Oswal Innovation Opportunities Fund Direct GrowthMOTILAL_OSWAL

3.57%

₹20 Cr

Invesco India Consumption Fund Direct GrowthINVESCO

3.24%

₹18 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

3.08%

₹73 Cr

LIC MF Healthcare Fund Direct GrowthLIC

2.97%

₹3 Cr

HSBC Consumption Fund Direct GrowthHSBC

2.77%

₹46 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

2.68%

₹8 Cr

Invesco India Business Cycle Fund Direct GrowthINVESCO

2.47%

₹30 Cr

Canara Robeco Mid Cap Fund Direct GrowthCANARA_ROBECO

2.41%

₹111 Cr

Analyse MEDANTA with Orion AI

Ask: "Is Global Health Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Global Health Ltd (MEDANTA) Stock

Global Health Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE474Q01031. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.